Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
August 25, 2021 at 08:34 am
Share
Baotou Dongbao Bio-Tech Co.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 276.670 million compared to CNY 186.782 million a year ago. Operating income was CNY 9.527 million compared to CNY 7.933 million a year ago. Net income was CNY 7.551 million compared to CNY 6.779 million a year ago. Basic earnings per share from continuing operations was CNY 0.0142 compared to CNY 0.0129 a year ago.
Baotou Dongbao Bio-Tech Co., Ltd is principally engaged in the research, development, manufacture and distribution of gelatin series products and low molecular mass collagen. The Company primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The Company distributes its products in both domestic and overseas markets, with domestic markets as its major markets.
BAOTOU DONGBAO BIO-TECH CO.,LTD 
